← 홈

ADC

1,032개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-7 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,032개
ADCBiologicstaleAstraZenecasPhase 3

Sonesitatug vedotin (Sonesitatug vedotin)

Gastric Cancer; Gastroesophageal Junction Adenocarcinoma · Gastric Cancer

#GastricCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 6상태 RECRUITING
ADCBiologicstaleAstraZenecaPreclinical

TDxd (TDxd)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+1
임상시험 6상태 RECRUITING
ADCBiologicstaleNeogap Therapeutics ABPhase 1

LNL (Tumor-draining lymph node-derived lymphocyte, Tumor-draining lymph node-derived lymphocyte (LNL))

Breast Neoplasms · Breast Neoplasms

#BreastNeoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 6상태 RECRUITING
ADCBiologicstaleSichuan Kelun-Biotech Biopharma…Phase 3

A166 (A166)

HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 5상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 1

AZD7789 (AZD7789)

Advanced or Metastatic NSCLC · Advanced or Metastatic NSCLC

#AdvancedorMetastaticNSCLC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 5상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

AZD9574 (AZD9574)

Advanced Solid Malignancies · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 5상태 RECRUITING
ADCBiologicstalePfizerPhase 2

BrECADD (BrECADD)

Hodgkin Lymphoma (Category) · Hodgkin Lymphoma (Category)

#HodgkinLymphomaCategory#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 5상태 RECRUITING
ADCBiologicstaleDualityBio Inc.Phase 3

DB-1303/BNT323 (DB-1303/BNT323)

HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 5상태 RECRUITING
ADCBiologicstaleGlaxoSmithKlinePhase 2

GSK3174998 (GSK3174998)

Neoplasms · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 11.1%임상시험 5상태 RECRUITING
ADCBiologicstaleGV20 TherapeuticsPhase 2

GV20-0251 (GV20-0251)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 5상태 RECRUITING
ADCBiologicstaleHansoh BioMedical R&D CompanyPhase 1

HS-20089 (HS-20089)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 5상태 RECRUITING
ADCBiologicstaleNational Cancer Institute (NCI)Phase 2

Larotrectinib Sulfate (Larotrectinib Sulfate)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 60%임상시험 5상태 RECRUITING
ADCBiologicstaleSanofiPhase 2

Pegenzileukin (Pegenzileukin)

Plasma Cell Myeloma Refractory · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 92.9%임상시험 5상태 RECRUITING
ADCBiologicstaleRayzeBio, Inc.Phase 2

RYZ101 (RYZ101)

Metastatic Breast Cancer; HER2-negative Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 5상태 RECRUITING
ADCBiologicstaleSanofiPhase 2

SAR3419 (SAR3419)

Diffuse Large B-cell Lymphoma · Acute Lymphocytic Leukaemia

#AcuteLymphocyticLeukaemia#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 5상태 ACTIVE
ADCBiologicstaleSeagen Inc.Phase 2

cBR96-Doxorubicin Immunoconjugate (SGN-15, SGN-15 (cBR96-Doxorubicin Immunoconjugate))

Ovarian Neoplasms · Ovarian Neoplasms

#OvarianNeoplasms#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 5상태 DISCONTINUED
ADCBiologicstaleSeagen Inc.Phase 1

SGN-CD33A (SGN-CD33A)

Acute Myelogenous Leukemia; Acute Myeloid Leukemia · CD33

#CD33#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 5상태 ACTIVE
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

SGN-LIV1A (SGN-LIV1A)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 34%임상시험 5상태 RECRUITING
ADCBiologicstaleCSPC Megalith Biopharmaceutical…Phase 2

SYS6002 (SYS6002)

Advanced Urothelial Carcinoma · Advanced Urothelial Carcinoma

#AdvancedUrothelialCarcinoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 5상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Talazoparib plus Irinotecan (Talazoparib plus Irinotecan)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 0.0%임상시험 5상태 RECRUITING

26 / 52 페이지

← 이전다음 →